Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening Accuracy

NARecruitingINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

December 31, 2025

Conditions
Randomized Controlled TrialProstate CancerMagnetic Resonance Imaging
Interventions
DIAGNOSTIC_TEST

bp-MRI prostate

Biparametric MRI is considered less comprehensive compared to multiparametric MRI (mp-MRI), which includes additional parameters like dynamic contrast-enhanced MRI (DCE-MRI). However, bp-MRI offers a simpler, faster, and often less expensive alternative that still provides critical diagnostic information, particularly in the detection of clinically significant prostate cancer. It's commonly used where less comprehensive assessment is sufficient or in situations where contrast use is contraindicated.

DIAGNOSTIC_TEST

mp-MRI prostate

Multiparametric MRI is highly valued for its ability to improve the detection and characterization of clinically significant prostate cancer, aid in biopsy guidance, and help in treatment planning and monitoring. Its comprehensive approach provides crucial insights that are not as readily available through simpler imaging modalities like biparametric MRI (bp-MRI).

Trial Locations (1)

333

RECRUITING

Chang Gung Memorial Hospital, Linkou, Taoyuan

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER